Fig. 1. Relationships of the disease progression course with eosinophil count and medication history. LDLT, living donor liver transplantation; POD, postoperative day; GVHD, graft-versus-host disease; CMV, cytomegalovirus; IVIG, intravenous immunoglobulin.

Ann Hepatobiliary Pancreat Surg 2021;25:551-5 https://doi.org/10.14701/ahbps.2021.25.4.551

© 2021 Ann Hepatobiliary Pancreat Surg